Medication for opioid use disorder in the Arab World: A systematic review

dc.contributor.authorAlawa, Jude
dc.contributor.authorMuhammad, Muzzammil Imran
dc.contributor.authorKazemitabar, Maryam
dc.contributor.authorBromberg, Daniel J.
dc.contributor.authorGarcia, Danilo
dc.contributor.authorKhoshnood, Kaveh
dc.contributor.authorGhandour, Lilian A.
dc.contributor.departmentEpidemiology and Population Health (EPHD)
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:34:57Z
dc.date.available2025-01-24T11:34:57Z
dc.date.issued2022
dc.description.abstractBackground: Opioid use disorder (OUD) is a global public health concern. The standard of care for OUD involves treatment using medications such as buprenorphine, methadone, or naltrexone. No known review exists to assess the contextual factors associated with medication for opioid use disorder (MOUD) in the Arab World. This systematic review serves as an implementation science study to address this research gap and improve the uptake of MOUD in the Arab World. Methods: Systematic searches of Medline, PsycINFO, and EMBASE, and a citation analysis, were used to identify peer-reviewed articles with original data on MOUD in the Arab World. Quality assessment was conducted using the CASP appraisal tools, and main findings were extracted and coded according to the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Results: 652 research articles were identified, and 10 met inclusion criteria for final review. Four studies considered health-systems aspects of MOUD administration, such as cost-effectiveness, the motivations for and impact of national MOUD policies, the types of social, political, and scientific advocacy that led to the adoption of MOUD in Arab countries, and the challenges limiting its wide-scale adoption in the Arab World. Six papers considered MOUD at individual and group patient levels by evaluating patient quality of life, addiction severity, patient satisfaction, and patient perspectives on opioid agonist therapy. Conclusion: Despite financial and geographic barriers that limit access to MOUD in the Arab World, this review found MOUD to be cost-effective and associated with positive health outcomes for OUD patients in the Arab World. MOUD can be successfully established and scaled to the national level in the Arab context, and strong coalitions of health practitioners can lobby to establish MOUD programs in Arab countries. Still, the relative novelty of MOUD in this context precludes an abundance of research to address its long-term delivery in the Arab World. © 2022
dc.identifier.doihttps://doi.org/10.1016/j.drugpo.2022.103617
dc.identifier.eid2-s2.0-85124584310
dc.identifier.pmid35182841
dc.identifier.urihttp://hdl.handle.net/10938/28260
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Journal of Drug Policy
dc.sourceScopus
dc.subjectArab world
dc.subjectImplementation science
dc.subjectMedication for opioid use disorder
dc.subjectOpioid agonist therapy
dc.subjectOpioid use disorder
dc.subjectSubstance use
dc.subjectAnalgesics, opioid
dc.subjectBuprenorphine
dc.subjectHumans
dc.subjectMethadone
dc.subjectOpiate substitution treatment
dc.subjectOpioid-related disorders
dc.subjectPharmaceutical preparations
dc.subjectQuality of life
dc.subjectNaloxone
dc.subjectOpiate agonist
dc.subjectDrug
dc.subjectNarcotic analgesic agent
dc.subjectAdoption
dc.subjectClinical evaluation
dc.subjectCost effectiveness analysis
dc.subjectDisease severity
dc.subjectEvidence based practice
dc.subjectHuman
dc.subjectOpiate addiction
dc.subjectPatient satisfaction
dc.subjectPerception
dc.subjectPolicy
dc.subjectQuality control
dc.subjectReview
dc.subjectSystematic review
dc.titleMedication for opioid use disorder in the Arab World: A systematic review
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1828.pdf
Size:
778.07 KB
Format:
Adobe Portable Document Format